Centessa, formed earlier this year through a ten-way merger involving multiple spinouts, has completed a listing in the US.

The health assessment software provider secured the funding in a series B round led by Bayer that also featured Samsung Catalyst Fund.

Johnson & Johnson’s investment arm has returned to back the molecular diagnostic technology developer, which also counts Novartis, Consort Medical and Wondfo Biotech as investors.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Lilly Asia Ventures took part in a $78m round for oncology therapy developer BH Med while gifting platform developer Snappy completed a $70m Hearst-backed series C.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The gamification of life continues, just updated for the modern world it seems.

Access Industries and Takeda scored exits as the oncology therapy developer floated at the top of its range in an upsized offering.

Zymergen has purchased Lodo Therapeutics, which is advancing Rockefeller research, for an undisclosed sum five years after the company raised its only funding round.

The GlaxoSmithKline and Celgene-backed immunotherapy developer has revealed its intention to float on the Nasdaq Global Market.